相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Blood immune cell biomarkers in lung cancer
D. Riemann et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2019)
Relationship Between Prior Radiotherapy and Checkpoint-Inhibitor Pneumonitis in Patients With Advanced Non-Small-Cell Lung Cancer
Khinh Ranh Voong et al.
CLINICAL LUNG CANCER (2019)
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
Tony S. K. Mok et al.
LANCET (2019)
Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non-Small Cell Lung Cancer: Results of the PEMBRO-RT Phase 2 Randomized Clinical Trial
Willemijn S. M. E. Theelen et al.
JAMA ONCOLOGY (2019)
Recruit or Reboot? How Does Anti-PD-1 Therapy Change Tumor-Infiltrating Lymphocytes?
Margaret K. Callahan et al.
CANCER CELL (2019)
Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater
Martin Reck et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
IL-6 Signaling Blockade during CD40-Mediated Immune Activation Favors Antitumor Factors by Reducing TGF-β, Collagen Type I, and PD-L1/PD-1
Emma Eriksson et al.
JOURNAL OF IMMUNOLOGY (2019)
The circulating pool of functionally competent NK and CD8+cells predicts the outcome of anti-PD1 treatment in advanced NSCLC
Giulia Mazzaschi et al.
LUNG CANCER (2019)
Excluding PTV from lung volume may better predict radiation pneumonitis for intensity modulated radiation therapy in lung cancer patients
Yinnan Meng et al.
RADIATION ONCOLOGY (2019)
Pneumonitis in Irradiated Lungs After Nivolumab: A Brief Communication and Review of the Literature
Farkhad Manapov et al.
JOURNAL OF IMMUNOTHERAPY (2018)
Th17 cells contribute to pulmonary fibrosis and inflammation during chronic kidney disease progression after acute ischemia
Purvi Mehrotra et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2018)
Progress and challenges of predictive biomarkers of anti PD-1/PD-L1 immunotherapy: A systematic review
Feifei Teng et al.
CANCER LETTERS (2018)
Immunotherapy and pulmonary toxicities: can concomitant immune-checkpoint inhibitors with radiotherapy increase the risk of radiation pneumonitis?
Guillaume Louvel et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
Julie R. Brahmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
The Role of Nrf2 in the Response to Normal Tissue Radiation Injury
Brent D. Cameron et al.
RADIATION RESEARCH (2018)
Pneumonitis in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy: Incidence and Risk Factors
Karthik Suresh et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Characteristics, incidence, and risk factors of immune checkpoint inhibitor related pneumonitis in patients with non-small cell lung cancer
Jun Yeun Cho et al.
LUNG CANCER (2018)
Pre-existing pulmonary fibrosis is a risk factor for anti-PD-1-related pneumonitis in patients with non-small cell lung cancer: A retrospective analysis
Teppei Yamaguchi et al.
LUNG CANCER (2018)
STING-dependent sensing of self-DNA drives silica-induced lung inflammation
Sulayman Benmerzoug et al.
NATURE COMMUNICATIONS (2018)
National Cancer Database Analysis of Proton Versus Photon Radiation Therapy in Non-Small Cell Lung Cancer
Kristin A. Higgins et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy
Jarushka Naidoo et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)
Leora Horn et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
Achim Rittmeyer et al.
LANCET (2017)
Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial
Narek Shaverdian et al.
LANCET ONCOLOGY (2017)
Nivolumab-induced interstitial lung disease analysis of two phase II studies patients with recurrent or advanced non-small-cell lung cancer
Terufumi Kato et al.
LUNG CANCER (2017)
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
S. J. Antonia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Functional T cells targeting tumor-associated antigens are predictive for recurrence-free survival of patients with radically operated non-small cell lung cancer
Seyer Safi et al.
ONCOIMMUNOLOGY (2017)
Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
I. Puzanov et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Incidence of Pneumonitis With Use of Programmed Death 1 and Programmed Death-Ligand 1 Inhibitors in Non-Small Cell Lung Cancer
Monica Khunger et al.
CHEST (2017)
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
J. B. A. G. Haanen et al.
ANNALS OF ONCOLOGY (2017)
Nivolumab induced radiation recall pneumonitis after two years of radiotherapy
R. Shibaki et al.
ANNALS OF ONCOLOGY (2017)
Successes and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer?
Jordi Remon et al.
BMC MEDICINE (2017)
Pembrolizumab for the treatment of PD-L1 positive advanced or metastatic non-small cell lung cancer
Thu Oanh Dang et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2016)
Pulmonary Radiation Recall Induced by Gemcitabine
Saadia A. Faiz et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Cancer immunotherapy: the beginning of the end of cancer?
Sofia Farkona et al.
BMC MEDICINE (2016)
Imbalance of peripheral blood Th17 and Treg responses in children with refractory Mycoplasma pneumoniae pneumonia
Hongmei Guo et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2016)
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
Louis Fehrenbacher et al.
LANCET (2016)
Synergistically increased ILC2 and Th9 cells in lung tissue jointly promote the pathological process of asthma in mice
Xinyu Ying et al.
MOLECULAR MEDICINE REPORTS (2016)
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Martin Reck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Pemetrexed-induced radiation recall dermatitis in a patient with lung adenocarcinoma: case report and literature review
Jin Ge et al.
JOURNAL OF THORACIC DISEASE (2016)
Immunological markers that predict radiation toxicity
Carl N. Sprung et al.
CANCER LETTERS (2015)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
Julie Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
H. Borghaei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Interleukin-6 and its receptors: A highly regulated and dynamic system
Janina Wolf et al.
CYTOKINE (2014)
Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice
Liufu Deng et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
RGMb is a novel binding partner for PD-L2 and its engagement with PD-L2 promotes respiratory tolerance
Yanping Xiao et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Serum Amyloid A as a Predictive Marker for Radiation Pneumonitis in Lung Cancer Patients
Yu-Shan Wang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Do Angiotensin-Converting Enzyme Inhibitors Reduce the Risk of Symptomatic Radiation Pneumonitis in Patients With Non-Small Cell Lung Cancer After Definitive Radiation Therapy? Analysis of a Single-Institution Database
Hongmei Wang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
MyD88 provides a protective role in long-term radiation-induced lung injury
Willie J. Brickey et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2012)
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Pulmonary Infection with Influenza A Virus Induces Site-Specific Germinal Center and T Follicular Helper Cell Responses
Alexander W. Boyden et al.
PLOS ONE (2012)
AN IMPROVED MODEL FOR PREDICTING RADIATION PNEUMONITIS INCORPORATING CLINICAL AND DOSIMETRIC VARIABLES
Peter Jenkins et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Nuclear factor-κB1 controls the functional maturation of dendritic cells and prevents the activation of autoreactive T cells
Dilan Dissanayake et al.
NATURE MEDICINE (2011)
Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer
Xiao Ding et al.
RADIATION ONCOLOGY (2011)
Second malignancies in breast cancer patients following radiotherapy: a study in Florence, Italy
Wei Zhang et al.
BREAST CANCER RESEARCH (2011)
INFLUENCE OF TECHNOLOGIC ADVANCES ON OUTCOMES IN PATIENTS WITH UNRESECTABLE, LOCALLY ADVANCED NON-SMALL-CELL LUNG CANCER RECEIVING CONCOMITANT CHEMORADIOTHERAPY
Zhongxing X. Liao et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Bleomycin and IL-1β-mediated pulmonary fibrosis is IL-17A dependent
Mark S. Wilson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
γδ T cells protect against lung fibrosis via IL-22
Philip L. Simonian et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Pathogenetic mechanisms in radiation fibrosis
John Yarnold et al.
RADIOTHERAPY AND ONCOLOGY (2010)
Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1
Christopher I. Amos et al.
NATURE GENETICS (2008)
Prediction of radiation-induced changes in the lung after stereotactic body radiation therapy of non-small-cell lung cancer
Ina Kyas et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Soluble TNF Mediates the Transition from Pulmonary Inflammation to Fibrosis
Nikos Oikonomou et al.
PLOS ONE (2006)
Retrospective analysis of steroid therapy for radiation-induced lung injury in lung cancer patients
Ikuo Sekine et al.
RADIOTHERAPY AND ONCOLOGY (2006)
Timeline - Radiation oncology: a century of achievements
J Bernier et al.
NATURE REVIEWS CANCER (2004)
The relevance of cytokines in the radiation-induced lung reaction.: Experimental basis and clinical significance
CE Rübe et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2004)
Epidemiology of environmental and occupational cancer
P Boffetta
ONCOGENE (2004)
Inherited predisposition to early onset lung cancer according to histological type
XJ Li et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking, and cancer risk
SJ Hwang et al.
HUMAN GENETICS (2003)
Gemcitabine-induced radiation recall
MD Jeter et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor β1
CG Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Circulating IL-6 as a predictor of radiation pneumonitis
YY Chen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
Transforming growth factor-beta(1) induces phenotypic modulation of human lung fibroblasts to myofibroblast through a c-jun-NH2-terminal kinase-dependent pathway
S Hashimoto et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer
TJ Robnett et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
Dose-dependent induction of transforming growth factor β (TGF-β) in the lung tissue of fibrosis-prone mice after thoracic irradiation
CE Rübe et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
分享论文
